In summary, our results reveal m6A modification levels are decreased and closely related to autophagic flux in ccRCC, and we also found that elevated expression of FTO is inhibited by rapamycin treatment, and silencing FTO impairs ccRCC growth and metastasis. The gene discussed is FTO; the disease is nonpapillary renal cell carcinoma.